AHC Research areas consists of a continuum of population science, translational, and basic science research targeting specific diseases with significant relevance to the population of Egypt, Africa and the world. The matrix is presented with the vertical columns representing the population studies and disease-based projects and the horizontal columns representing the available state-of-the-art science and engineering platforms available at AHC.
A fundamental component of AHC’s mission is to develop and promote a well-designed landscape of ‘Platforms of integrated Healthcare and Research’. These platforms are strengthening AHC in being a Centre of Excellence in Patient Care and Cardiovascular Research. Our Molecular and Biomedical Engineering Platforms include cutting-edge laboratories that allow investigating disease from cellular and molecular research to advanced patient-specific imaging as well as computational modeling. Figure: Matrix is presented with the vertical columns representing the disease-based research projects and the horizontal columns representing the available state-of-the-art science and engineering platforms available in the Centr
Population science is particularly important as it sets the frame for all the other programmes at AHC. It helps us understand ethnic and racial disparities in the population burden of CVD, which is crucial to effective prevention and treatment. Important examples worldwide include the Framingham study, the Dallas Heart Study in the US, the Copenhagen City Heart Study in Denmark, and the Lollipop study in West London. To date there has been no similar studies in Egypt or the Middle East.
based Programme, highlighting background/relevance, objectives, progress to date and future directions. Data regarding cardiovascular disease prevalence in African countries including Egypt is scarce. Population and epidemiological Studies at AHC will help producing high quality data that are crucial to improving health policy and reducing preventable deaths.
- Ballana Heart Study
- 1000 Egyptian Genome (E-HVOL)
disease based projects
Diseases studied in the AHC research Programme were chosen because of:
- Their known impact on the country/prevalence In the Egyptian population
- Parallel the clinical activity
- Inherited Heart Muscle Disease and Channelopathies
- Coronary Artery Disease (CAD)
- BAV & Aortopathy
- Congenital Heart Disease (CHD)
- The existing expertise and experience in the centre, both clinical service and technical expertise
- Their relevance for capacity building, training and higher education
- Heart Failure
- Aortic Root Structure & Function
- Rheumatic Heart Disease (RHD)
- Pulmonary Hypertension